Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unmasking Osmotic Demyelination Syndrome/Extrapontine Myelinolysis in Acute Intermittent Porphyria: Preventable Complications-Challenges in Diagnosis and Management. | Ann Indian Acad Neurol | 2025 | 40119789 | PubTator, text mining | PubMed |
| A novel HMBS gene mutation in acute intermittent porphyria: a case report of abdominal pain, seizures, and reversible neuroimaging findings. | Front Genet | 2025 | 40110035 | PubTator, text mining | PubMed |
| Developing a dynamic combined power quality index for assessing the performance of a nuclear facility. | Sci Rep | 2025 | 40000648 | PubTator, text mining | PubMed |
| A case report of acute intermittent porphyria presenting with reversible cerebral vasoconstriction syndrome. | Medicine (Baltimore) | 2025 | 39993084 | PubTator, text mining | PubMed |
| Bringing theory to life: integrating case-based learning in applied physiology for undergraduate physiotherapy education. | BMC Med Educ | 2025 | 39948535 | PubTator, text mining | PubMed |
| An easily overlooked disease in the early stages: acute intermittent porphyria. | BMC Neurol | 2025 | 39948482 | PubTator, text mining | PubMed |
| Hierarchical Resources Management System for Internet of Things-Enabled Smart Cities. | Sensors (Basel) | 2025 | 39943255 | PubTator, text mining | PubMed |
| Microenvironment-Specific Enrichment Strategy Enables Lysosomal Proteomic Dynamics Analysis. | Anal Chem | 2025 | 39901599 | PubTator, text mining | PubMed |
| A novel acquired resistance mechanism to 5-aminolevulinic acid-mediated photodynamic therapy with ABCG2 inhibition. | Photochem Photobiol | 2025 | 39900503 | PubTator, text mining | PubMed |
| Porphyric encephalopathy in a 15-year-old girl: A case report. | SAGE Open Med Case Rep | 2025 | 39881736 | PubTator, text mining | PubMed |
| Oversized cells activate global proteasome-mediated protein degradation to maintain cell size homeostasis. | Elife | 2025 | 39791360 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| Minimally Invasive Unilateral Pedicle Combined With Contralateral Translaminar Facet Joint Screw Fixation for Single-Segment Lumbar Degenerative Disease: A 10-Year Follow-Up Study. | Spine (Phila Pa 1976) | 2025 | 39588666 | PubTator, text mining | PubMed |
| Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates. | Gut | 2025 | 39366725 | PubTator, text mining | PubMed |
| Assessing predictions on fitness effects of missense variants in HMBS in CAGI6. | Hum Genet | 2025 | 39110250 | PubTator, text mining | PubMed |
| Acute Intermittent Porphyria in an Adolescent Patient: Diagnostic and Treatment Challenges. | Cureus | 2024 | 39737264 | PubTator, text mining | PubMed |
| Cost-effectiveness analysis of AI-based image quality control for perinatal ultrasound screening. | BMC Med Educ | 2024 | 39696216 | PubTator, text mining | PubMed |
| Comparison of two UPS regulators: the 26S proteasome LID and the COP9 signalosome. | Front Cell Dev Biol | 2024 | 39600336 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system in Plasmodium: a potential antimalarial target to overcome resistance - a systematic review. | Front Med (Lausanne) | 2024 | 39497850 | PubTator, text mining | PubMed |
| Human Chorionic Gonadotropin (hCG) Injections Exacerbating Acute Intermittent Porphyria in a 34-Year-Old Woman. | Cureus | 2024 | 39371821 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers?page=7